SEC Filings - Marker Therapeutics, Inc.

Filing date	Form	Description	View
Jan 29, 2016	SC 13G/A	An amendment to the SC 13G filing	0001213900-16-010454.pdf 0001213900-16-010454.rtf 0001213900-16-010454.xls View HTML
Jan 28, 2016	3	Initial filing by director officer or owner of more than ten percent.	0000899243-16-012296.pdf 0000899243-16-012296.rtf View HTML
Jan 28, 2016	4	Statement of changes in beneficial ownership of securities	0000899243-16-012297.pdf 0000899243-16-012297.rtf View HTML
Jan 27, 2016	8-K	Report of unscheduled material events or corporate event	0001193125-16-439649.pdf 0001193125-16-439649.rtf 0001193125-16-439649.xls View HTML
Jan 19, 2016	SC 13G/A	An amendment to the SC 13G filing	0000902664-16-004887.pdf 0000902664-16-004887.rtf 0000902664-16-004887.xls View HTML
Dec 11, 2015	8-K	Report of unscheduled material events or corporate event	0001424884-15-000181.pdf 0001424884-15-000181.rtf 0001424884-15-000181.xls View HTML
Nov 20, 2015	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	0001424884-15-000172.pdf 0001424884-15-000172.rtf 0001424884-15-000172.xls View HTML
Nov 20, 2015	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	0001424884-15-000174.pdf 0001424884-15-000174.rtf 0001424884-15-000174.xls View HTML
Nov 16, 2015	4	Statement of changes in beneficial ownership of securities	0000899243-15-008209.pdf 0000899243-15-008209.rtf View HTML
Nov 16, 2015	4	Statement of changes in beneficial ownership of securities	0000899243-15-008211.pdf 0000899243-15-008211.rtf View HTML

Data provided by Kaleidoscope.